Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
47,622,569
-
Share change
-
+47,621,269
-
Total reported value
-
$349,319,767
-
Put/Call ratio
-
0.25%
-
Price per share
-
$7.35
-
Number of holders
-
82
-
Value change
-
+$349,310,767
-
Number of buys
-
81
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2017
As of 30 Jun 2017,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,622,569 shares.
The largest 10 holders included
BlackRock Inc., FRANKLIN RESOURCES INC, PERCEPTIVE ADVISORS LLC, venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, ORBIMED ADVISORS LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, and VANGUARD GROUP INC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.